Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
BACKGROUND: Although dihydroartemisinin-piperaquine (DP) is used primarily in children, pharmacokinetic/pharmacodynamic (PK/PD) data on DP use in young children are lacking. METHODS: We conducted a prospective PK/PD study of piperaquine in 107 young children in Uganda. Samples were collected up to 2...
Main Authors: | Creek, D, Bigira, V, McCormack, S, Arinaitwe, E, Wanzira, H, Kakuru, A, Tappero, J, Sandison, T, Lindegardh, N, Nosten, F, Aweeka, F, Parikh, S |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2013
|
Títulos similares
-
Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
por: Tchaparian, E, et al.
Publicado: (2016) -
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
por: Kamya Moses, et al.
Publicado: (2009-01-01) -
Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
por: Tarning, J, et al.
Publicado: (2012) -
Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
por: Tarning, J, et al.
Publicado: (2012) -
Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
por: Rijken, M, et al.
Publicado: (2011)